LivaNova PLC (LIVN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - LivaNova is a global medtech company with approximately $1.3 billion in revenue over the last 12 months as of September of the previous year, boasting nearly five decades of experience in the industry [4]. Recent Developments - The company has seen improvements in reimbursement for its Epilepsy business, which is a significant positive development [2]. - CORE-VNS data was presented at the American Epilepsy Society, highlighting advancements in the company's offerings [2]. - A manuscript covering durability data for the RECOVER study in difficult-to-treat depression has been published, indicating ongoing research and development efforts [2].